Oramed Pharmaceuticals (XTAE:ORMP) 3-Year Book Growth Rate : 43.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Oramed Pharmaceuticals 3-Year Book Growth Rate?

Oramed Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was ₪15.14.

During the past 12 months, Oramed Pharmaceuticals's average Book Value per Share Growth Rate was 5.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was 43.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was 28.10% per year. During the past 10 years, the average Book Value per Share Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Oramed Pharmaceuticals was 80.90% per year. The lowest was -17.50% per year. And the median was 14.05% per year.

Competitive Comparison of Oramed Pharmaceuticals's 3-Year Book Growth Rate

For the Biotechnology subindustry, Oramed Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oramed Pharmaceuticals's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's 3-Year Book Growth Rate falls into.

Oramed Pharmaceuticals 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Oramed Pharmaceuticals (XTAE:ORMP) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Oramed Pharmaceuticals 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oramed Pharmaceuticals (XTAE:ORMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (XTAE:ORMP) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ORMP:USA OJU1:Germany

Address

1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036

Website

https://www.oramed.com

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.